{"id":"enzacamene","rwe":[{"pmid":"41730063","year":"2006","title":"Sunscreens.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"41365477","year":"2026","title":"Toxicity assessment of organic UV filters Benzophenone-3 (BP-3) and Enzacamene (4-MBC) using the freshwater planarian Girardia tigrina.","finding":"","journal":"Environmental toxicology and pharmacology","studyType":"Clinical Study"},{"pmid":"40215953","year":"2025","title":"Effects of ultra-violet filters oxybenzone (benzophenone-3) and 4-methylbenzylidene camphor on different life-history traits of the copepod Acartia tonsa Dana.","finding":"","journal":"Marine pollution bulletin","studyType":"Clinical Study"},{"pmid":"39044045","year":"2024","title":"Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active Ingredients.","finding":"","journal":"Pharmaceutical research","studyType":"Clinical Study"},{"pmid":"37313630","year":"2023","title":"LC-MS profiling-based non-targeted secondary metabolite screening for deciphering cosmeceutical potential of Malaysian algae.","finding":"","journal":"Journal of cosmetic dermatology","studyType":"Clinical Study"}],"tags":[{"label":"enzacamene","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Topical","category":"route"},{"label":"Cream","category":"form"},{"label":"Spray","category":"form"},{"label":"Active","category":"status"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ENZACAMENE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:56:21.732223+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:56:26.948696+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ENZACAMENE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:56:27.280609+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104261/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:56:27.989014+00:00"}},"allNames":"methylbenzylidenecam","offLabel":[],"synonyms":["enzacamene","methylbenzylidenecam","4-Methylbenzylidenecamphor","p-Methylbenzylidenecamphor"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Methylbenzylidenecam","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"enzacamene","explanation":"","oneSentence":"","technicalDetail":"Enzacamene's mechanism of action is not well understood, but it is believed to involve the inhibition of a specific enzyme or protein, leading to a cascade of downstream effects that can impact disease progression."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4292","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ENZACAMENE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ENZACAMENE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:01:34.283989","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:56:29.649345+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"genericName":"enzacamene","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00530387","phase":"NA","title":"Multi-Centre European Photopatch Test Study","status":"COMPLETED","sponsor":"NHS Tayside","startDate":"2008-07","conditions":["Dermatitis, Photocontact"],"enrollment":1000,"completionDate":"2011-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Cream, Spray","formulations":[{"form":"CREAM","route":"TOPICAL","productName":"NWC 21 NATURAL PREMIUM BB CREAM"},{"form":"CREAM","route":"TOPICAL","productName":"QT SUN BLOCK"},{"form":"CREAM","route":"TOPICAL","productName":"Correway Sunscreen (Waterproof)"},{"form":"CREAM","route":"TOPICAL","productName":"NATURAL SUN AQ BODY AND FAMILY MILD SUN MILK"},{"form":"CREAM","route":"TOPICAL","productName":"NATURAL SUN AQ TOTAL ANTI-AGING ESSENCE SUN"},{"form":"CREAM","route":"TOPICAL","productName":"Conju Princess UV Sun Block"},{"form":"CREAM","route":"TOPICAL","productName":"Laser Block 100sunblock"},{"form":"CREAM","route":"TOPICAL","productName":"MediSpa Sunblocksunblock"},{"form":"CREAM","route":"TOPICAL","productName":"Outback  2-in-1Insect Repellent and Protective Sunscreen"},{"form":"SPRAY","route":"TOPICAL","productName":"MediSpa SunSpraysunblock"}]},"crossReferences":{"NDDF":"006716","UNII":"8I3XWY40L9","CHEBI":"CHEBI:135937","INN_ID":"7899","RXNORM":"1311507","UMLSCUI":"C0094910","chemblId":"CHEMBL2104261","ChEMBL_ID":"CHEMBL4297074","KEGG_DRUG":"D04013","DRUGBANK_ID":"DB11219","PUBCHEM_CID":"6434217","SNOMEDCT_US":"256180000","MESH_SUPPLEMENTAL_RECORD_UI":"C038939"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":10,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2006","pmid":"41730063","title":"Sunscreens.","journal":""},{"date":"2026 Jan","pmid":"41365477","title":"Toxicity assessment of organic UV filters Benzophenone-3 (BP-3) and Enzacamene (4-MBC) using the freshwater planarian Girardia tigrina.","journal":"Environmental toxicology and pharmacology"},{"date":"2025 Jul","pmid":"40215953","title":"Effects of ultra-violet filters oxybenzone (benzophenone-3) and 4-methylbenzylidene camphor on different life-history traits of the copepod Acartia tonsa Dana.","journal":"Marine pollution bulletin"},{"date":"2024 Aug","pmid":"39044045","title":"Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active Ingredients.","journal":"Pharmaceutical research"},{"date":"2023 Oct","pmid":"37313630","title":"LC-MS profiling-based non-targeted secondary metabolite screening for deciphering cosmeceutical potential of Malaysian algae.","journal":"Journal of cosmetic dermatology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":null},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:56:29.649345+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}